Nevertheless, these results provide the first evidence that BET family members have critical functions in AR-regulated gene expression and raise the possibility that chemical inhibition of their recruitment to chromatin may have therapeutic potential in blocking prostate cancer cell growth. This evidence concerns the gene DNER and prostate carcinoma.